A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
Conditions
- Locally Advanced or Metastatic Solid Tumors
Interventions
- DRUG: ATG-037
- DRUG: KEYTRUDA ®( Pembrolizumab)
Sponsor
Antengene Therapeutics Limited
Collaborators